Gluskin Sheff & Assoc Inc Astrazeneca PLC Transaction History
Gluskin Sheff & Assoc Inc
- $788 Million
- Q2 2025
A detailed history of Gluskin Sheff & Assoc Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Gluskin Sheff & Assoc Inc holds 14,574 shares of AZN stock, worth $1.23 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
14,574
Previous 28,414
48.71%
Holding current value
$1.23 Million
Previous $2.09 Million
51.25%
% of portfolio
0.13%
Previous 0.28%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,446Shares Held
497MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.37 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.46 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.64 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.62 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $261B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...